StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
CGENCOMPUGEN LTD
stockpulse.co.kr
Nasdaq
$1.94▲ 0.26%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $183.4MShares out 94.5M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

15
  • 9.10After-hours26.09.11 05:05
    6-KKey event#●●●

    COMPUGEN LTD

    Compugen Ltd. announced that all proposals presented at its 2026 Annual General Meeting of Shareholders held on September 10, 2026, were approved by the requisite majority vote. This confirms shareholder approval for the company's upcoming management and key decision-making processes.…more

    $1.94+0.26%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 8.3Pre-market26.08.03 21:00
    6-KKey event

    COMPUGEN LTD

    컴퓨젠(Compugen Ltd.)은 2026년 9월 10일 이스라엘 홀론에서 연례 주주총회를 개최할 예정입니다. 이번 총회에서는 이사 8명 선임, 보상 정책 개정, 외부감사인 재선임 안건을 의결하며, 2025년 회계연도 감사 재무제표에 대한 논의가 진행됩니다.…more

    $1.94+0.26%vs prev close
    View filingShare
  • 8.3Pre-market26.08.03 20:02
    6-KKey event

    COMPUGEN LTD

    컴퓨젠(Compugen)은 2026년 2분기 실적 발표를 통해 매출 260만 달러, 순손실 700만 달러를 기록했다고 밝혔다. 현재 약 1억 2,530만 달러의 현금성 자산을 보유하여 2029년까지 운영 자금을 확보했으며, 핵심 파이프라인인 MAIA-ovarian 임상시험의 중간 분석 결과를 2027년 1분기에 발표할 예정이다.…more

    $1.94+0.26%vs prev close
    View filingShare

14 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire

No news collected yet. New articles will appear here.